Physician and Patient Barriers to Breast Cancer Preventive Therapy

The uptake of selective estrogen receptor modulators (SERMs) and aromatase inhibitors (AIs) for the primary prevention of breast cancer is low, despite their proven efficacy in several randomized clinical trials. This review summarizes the latest data on physicians’ and women’s barriers to breast ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Hum, Susan, Wu, Melinda, Pruthi, Sandhya, Heisey, Ruth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Risk and Prevention (TB Bevers, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995234/
https://www.ncbi.nlm.nih.gov/pubmed/27617055
http://dx.doi.org/10.1007/s12609-016-0216-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995234/
https://www.ncbi.nlm.nih.gov/pubmed/27617055
http://dx.doi.org/10.1007/s12609-016-0216-5

Ejemplares similares